2013;2013:972913 Burgunder JM, Varriale A, Lauterburg BH
Taking into account the above-mentioned considerations on cost and safety aspects, oral small molecule agonists stimulating endogenous GLP-1 secretion by intestinal L-cells may offer a promising alternative for developing new treatments for Type 2 diabetes and obesity
doi:10.1007/s00125-010-1896-4 29
And the comments, people are so shocked, so blown away" TikTok7.6M views @amyinhalf's loose skin and GLP-1 claims, fact-checked @amyinhalf "Ozempic causes so much loose skin
The most common side effects of tirzepatide are gastrointestinal, including nausea (12-24%), diarrhea (12-17%), vomiting (6-10%), constipation (6-11%), and decreased appetite